Table of Contents
TABLE OF
CONTENTS………………………………………………………................I
ABSTRACT……………………………………………………………………………….III
LIST OF TABLES….…………………………………………………………...............IV
LIST OF
FIGURES…….……………………………………………………..................V
NOMENCLATURE…………………………………………………………..................VI
1. INTRODUCTION………………………………………………………. ...1
1.1 CHARACTERISTICS OF THE PRION DISEASES……………1
1.1 .1 General
Features of the Prion Diseases………………..1
1.1.2 Prion Diseases: Etiology,
Transmission, Clinical Presentation
and Treatment……………………………...2
1.2 MOLECULAR PROPERTIES OF THE PRION PROTEIN……5
1.2.1 Structure of the
Prion Protein…………………………….5
1.2.2 Function of the Prion
Protein…………………………. …7
1.2.3 Genetics of the Prion
Protein…………………………….8
1.2.4 Prions in Yeast and
Fungi………………………………..9
1.3 CELLULAR TRAFFICKING OF THE PRION PROTEIN ……10
1.4 THE PRINCIPLES AND APPLICATIONS OF THE
ATOMIC
FORCE
MICROSCOPY ………………………………………..13
1.4.1 Atomic
Force Microscope……………………………….13
1.4.2 General
Principles of AFM………………………………13
1.5 AMYLOID IN PRION DISEASES………………………………15
1.5.1 Formation of Amyloid……………………………………15
1.5.2 Amyloid under AFM……………………………………..17
2. MATERIALS AND METHODS……………………………………….....19
2.1 MATERIALS……………………………………………………...19
2.1.1 Chemicals, Buffers,
Solutions, Reagents and Media...19
2.1.2
Disposable
Materials…………………………………… 19
2.1.3
Antibodies…………………………………………………20
2.1.4
Cell
Lines………………………………………………….20
2.1.5
Hardware………………………………………………….20
2.1.6
Software…………………………………………………..20
2.2 METHODS………………………………………………………..21
2.2.1 Cell Fixation for AFM
and Immunofluorescence……...21
2.2.2 Immunofluorescence
Detection of PrPc / PrPSc ………21
2.2.3
Imaging
of Immunofluorescence Labeled Samples….22
2.2.4
Atomic
Force Microscopy Setup……………………….22
2.2.5
Image
Processing………………………………………..22
3. RESULTS…………………………………………………………………23
3.1 INDIRECT IMMUNOFLUORESCENCE OF PrP ON
THE SURFACE OF NORMAL AND INFECTED N2A
CELLS…….23
3.2 CELL SURFACE STRUCTURES IN SCRAPIE-INFECTED
AND NON-INFECTED CELL CULTURES……………………24
4. DISCUSSION…………………………………………………………….35
REFERENCES…………………………………………………………………………..38
HONOUR
STATEMENT……………………………………………………................43